[go: up one dir, main page]

GB0408076D0 - Pharmaceutical formulations - Google Patents

Pharmaceutical formulations

Info

Publication number
GB0408076D0
GB0408076D0 GB0408076A GB0408076A GB0408076D0 GB 0408076 D0 GB0408076 D0 GB 0408076D0 GB 0408076 A GB0408076 A GB 0408076A GB 0408076 A GB0408076 A GB 0408076A GB 0408076 D0 GB0408076 D0 GB 0408076D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical formulations
formulations
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0408076A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Priority to GB0408076A priority Critical patent/GB0408076D0/en
Publication of GB0408076D0 publication Critical patent/GB0408076D0/en
Priority to KR1020067020770A priority patent/KR101239446B1/en
Priority to US11/547,226 priority patent/US9168224B2/en
Priority to EP05733580.4A priority patent/EP1734927B8/en
Priority to ES05733580T priority patent/ES2389443T3/en
Priority to SI200531566T priority patent/SI1734927T1/en
Priority to BRPI0509708A priority patent/BRPI0509708B8/en
Priority to CN2005800079205A priority patent/CN1929818B/en
Priority to PT05733580T priority patent/PT1734927E/en
Priority to AU2005230401A priority patent/AU2005230401B2/en
Priority to CA2556993A priority patent/CA2556993C/en
Priority to PCT/EP2005/003669 priority patent/WO2005097068A1/en
Priority to RU2006138998/15A priority patent/RU2375044C2/en
Priority to DK05733580.4T priority patent/DK1734927T3/en
Priority to PL05733580T priority patent/PL1734927T3/en
Priority to JP2007506729A priority patent/JP5021456B2/en
Priority to HK07105470.1A priority patent/HK1099211A1/en
Priority to CY20121100755T priority patent/CY1113060T1/en
Ceased legal-status Critical Current

Links

GB0408076A 2004-04-08 2004-04-08 Pharmaceutical formulations Ceased GB0408076D0 (en)

Priority Applications (18)

Application Number Priority Date Filing Date Title
GB0408076A GB0408076D0 (en) 2004-04-08 2004-04-08 Pharmaceutical formulations
JP2007506729A JP5021456B2 (en) 2004-04-08 2005-04-07 Pimecrolimus foam composition comprising hexylene glycol, optionally oleyl alcohol, dimethyl isosorbide and / or medium chain triglycerides
PT05733580T PT1734927E (en) 2004-04-08 2005-04-07 Pimecrolimus foam composition containing hexylene glycol, optionally oleyl alcohol, dimethylisosorbide and/or medium chain triglycerides
CA2556993A CA2556993C (en) 2004-04-08 2005-04-07 Pimecrolimus foam composition containing hexylene glycol, optionally oleyl alcohol, dimethylisosorbide and/or medium chain triglycerides
EP05733580.4A EP1734927B8 (en) 2004-04-08 2005-04-07 Pimecrolimus foam composition containing hexylene glycol, optionally oleyl alcohol, dimethylisosorbide and/or medium chain triglycerides
ES05733580T ES2389443T3 (en) 2004-04-08 2005-04-07 Composition of pimecrolimus foam containing hexylene glycol, optionally oleyl alcohol, dimethylisoorbide and / or medium chain triglycerides
SI200531566T SI1734927T1 (en) 2004-04-08 2005-04-07 Pimecrolimus foam composition containing hexylene glycol, optionally oleyl alcohol, dimethylisosorbide and/or medium chain triglycerides
BRPI0509708A BRPI0509708B8 (en) 2004-04-08 2005-04-07 pharmaceutical foam, pimecrolimus foam composition containing hexylene glycol, optionally oleyl alcohol, dimethyl isosorbide and/or medium chain triglycerides and usage
CN2005800079205A CN1929818B (en) 2004-04-08 2005-04-07 Pimecrolimus foam compositions containing hexylene glycol, optionally oleyl alcohol, dimethyl isosorbide and/or medium chain triglycerides
KR1020067020770A KR101239446B1 (en) 2004-04-08 2005-04-07 Pimecrolimus foam composition containing hexylene glycol, optionally oleyl alcohol, dimethylisosorbide and/or medium chain triglycerides
AU2005230401A AU2005230401B2 (en) 2004-04-08 2005-04-07 Pimecrolimus foam composition containing hexylene glycol, optionally oleyl alcohol, dimethylisosorbide and/or medium chain triglycerides
US11/547,226 US9168224B2 (en) 2004-04-08 2005-04-07 Pimecrolimus foam composition containing hexylene glycol, optionally oleyl alcohol, dimethylisosorbide and/or medium chain triglycerides
PCT/EP2005/003669 WO2005097068A1 (en) 2004-04-08 2005-04-07 Pimecrolimus foam composition containing hexylene glycol, optionally oleyl alcohol, dimethylisosorbide and/or medium chain triglycerides
RU2006138998/15A RU2375044C2 (en) 2004-04-08 2005-04-07 Pimecrolimus foamy composition including hexylene glycol, optionally oleyl alkohol and/or medium chain triglycerides
DK05733580.4T DK1734927T3 (en) 2004-04-08 2005-04-07 Pimecrolimus foam composition containing hexylene glycol, optionally oleyl alcohol, dimethyl isosorbide and / or medium chain triglycerides
PL05733580T PL1734927T3 (en) 2004-04-08 2005-04-07 Pimecrolimus foam composition containing hexylene glycol, optionally oleyl alcohol, dimethylisosorbide and/or medium chain triglycerides
HK07105470.1A HK1099211A1 (en) 2004-04-08 2007-05-23 Pimecrolimus foam composition containing hexylene glycol, optionally oleyl alcohol, dimethylisosorbide and/or medium chain triglycerides
CY20121100755T CY1113060T1 (en) 2004-04-08 2012-08-23 COMPOSITION OF AFTER PIMECROLIMES CONTAINING LYSYLENE GLYCL, OPTIONAL OLIVE ALCOHOL, DIMETHYLSORPHORIDE AND / OR MEDICINE ALSYRID

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0408076A GB0408076D0 (en) 2004-04-08 2004-04-08 Pharmaceutical formulations

Publications (1)

Publication Number Publication Date
GB0408076D0 true GB0408076D0 (en) 2004-05-12

Family

ID=32320643

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0408076A Ceased GB0408076D0 (en) 2004-04-08 2004-04-08 Pharmaceutical formulations

Country Status (1)

Country Link
GB (1) GB0408076D0 (en)

Similar Documents

Publication Publication Date Title
IL177566A0 (en) Pharmaceutical formulations
GB0426301D0 (en) Pharmaceutical formulations
IL223545A0 (en) Pharmaceutical compositions
IL179809A0 (en) Pharmaceutical compositions
GB0408308D0 (en) Pharmaceutical compositions
GB0302671D0 (en) Pharmaceutical formulations
IL172824A0 (en) Pharmaceutical formulations
GB0302672D0 (en) Pharmaceutical formulations
PL1837019T3 (en) Orally-dispersible pharmaceutical compositions
GB0416397D0 (en) Pharmaceutical formulations
GB0423800D0 (en) New pharmaceutical formulations
HK1105358A1 (en) Solid pharmaceutical formulation
EP1805154A4 (en) Pharmaceutical compositions
GB0316341D0 (en) Pharmaceutical formulations
GB0406048D0 (en) Drug formulations
GB0407351D0 (en) Pharmaceutical compositions
GB0400971D0 (en) Pharmaceutical compositions
EP1716865A4 (en) Paraoxonase-containing pharmaceutical preparation
GB0422582D0 (en) Pharmaceutical compositions
GB0411502D0 (en) Pharmaceutical compositions
GB0428010D0 (en) Pharmaceutical formulations
GB0408076D0 (en) Pharmaceutical formulations
GB0408070D0 (en) Pharmaceutical formulations
GB0316335D0 (en) Pharmaceutical formulations
GB0417777D0 (en) Pharmaceutical combination

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)